Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

9.60

+0.11 (1.16%)

At close: Dec 5, 2025, 4:00 PM EST

9.60

0.00 (0.00%)

After-hours: Dec 5, 2025, 5:01 PM EST

Anika Therapeutics Market Cap

Anika Therapeutics has a market cap or net worth of $138.44 million as of December 5, 2025. Its market cap has decreased by -44.53% in one year.

Market Cap

138.44M

Enterprise Value

104.96M

1-Year Change

-44.53%

Ranking

#4036

Market Cap Chart

Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $138.44M, an increase of 170.40%. That is a compound annual growth rate of 3.75%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	136.90M	-43.22%
Dec 31, 2024	241.10M	-27.34%
Dec 29, 2023	331.80M	-23.27%
Dec 30, 2022	432.40M	-16.41%
Dec 31, 2021	517.30M	-19.59%
Dec 31, 2020	643.30M	-13.06%
Dec 31, 2019	739.90M	54.92%
Dec 31, 2018	477.60M	-39.57%
Dec 29, 2017	790.40M	10.39%
Dec 30, 2016	716.00M	28.18%
Dec 31, 2015	558.60M	-5.47%
Dec 31, 2014	590.90M	12.00%
Dec 31, 2013	527.60M	284.27%
Dec 31, 2012	137.30M	2.85%
Dec 30, 2011	133.50M	48.50%
Dec 31, 2010	89.90M	2.98%
Dec 31, 2009	87.30M	152.31%
Dec 31, 2008	34.60M	-78.71%
Dec 31, 2007	162.50M	14.12%
Dec 29, 2006	142.40M	16.06%
Dec 30, 2005	122.70M	31.51%
Dec 31, 2004	93.30M	-4.11%
Dec 31, 2003	97.30M	892.86%
Dec 31, 2002	9.80M	-1.01%
Dec 31, 2001	9.90M	26.92%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	936.68B
Johnson & Johnson	494.92B
AbbVie	396.55B
UnitedHealth Group	293.98B
AstraZeneca	282.37B
Novartis AG	253.36B
Merck & Co.	250.76B
Abbott Laboratories	219.65B

Market Cap Rankings